Nutrition, Immunology and Epidemiology of Tuberculosis
Completed · Phase 3 · Has a placebo group
Conditions studied: Tuberculosis
In brief
The purpose of this study is to determine the efficacy of micronutrient supplementation among patients with active tuberculosis, half of who are co-infected with HIV-1
Key facts
- Study ID
- NCT00197704
- Run by
- Harvard School of Public Health (HSPH)
- People needed
- 876
- Starts
- 2000-03-01
- Expected to finish
- 2004-05-01
- Last updated by the study team
- 2010-11-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women, age 18 to 60 years inclusive
- At least two positive sputum smears for tuberculosis
- Intention to stay in Dar-es-Salaam for at least 2 years after the start of TB therapy
- Subjects who grant informed consent to participation
You may not qualify if…
- Karnofsky score < 40%
- Hemoglobin < 8.5 g/dl
- Having had treatment for TB exceeding 4 weeks in the last 5 years
- Pregnant women
Where it is running
- Harvard School of Public Health — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.